A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine
Clinical trial NCT03560245 · COMPLETED
Trial details
- NCT number
- NCT03560245
- Sponsor
- Neurotrope Bioscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-20
- Primary completion
- 2019-07-25
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.